Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
about
Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.C-X-C motif receptor 7 in gastrointestinal cancer.Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Cancer subclonal genetic architecture as a key to personalized medicine.CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.Current and future intratumoral targeted treatment for pancreatic cancer.CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer.Cancer associated fibroblasts: An essential role in the tumor microenvironment.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationExosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis.
P2860
Q35550177-63539B16-19AF-4D02-B0C4-2B3E8B1B0D5DQ35739397-EADCD122-4616-4E87-AE6E-37E28EB82CBAQ35856680-EF9D6DE8-F2F1-430E-833F-86A690CDC380Q37176648-06C1CB45-FF69-4F85-B223-C7143F96C8B5Q37448116-8EC685FA-7B79-4C99-A93E-E33A72AB9E1DQ38209604-68CD2EE7-50B0-4831-A4BE-0C8BF839E603Q38261961-A71277B8-1909-4F9E-A225-1C22EFFE8659Q38789650-4B8BAF79-6C46-45E3-A65C-9644A268C98AQ38847430-086A2118-8153-47D2-BD1C-6A83CECA656AQ38873247-71871CEE-552D-4F40-BAF6-DE0A7C8EEA38Q38978463-96615983-9BD1-40A3-BC1A-5A7068358A7DQ41191081-2428B3F3-62DB-4EAA-81A2-AC62409C2E54Q41614004-6EE68355-0504-45D8-B21D-25CE880541C6Q41879186-D1C9E85B-36CA-40DA-A842-62546E19C8D9Q42121985-EA24CAD9-E500-4038-A2A4-40ADED24591C
P2860
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@ast
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@en
type
label
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@ast
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@en
prefLabel
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@ast
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@en
P2093
P2860
P356
P1433
P1476
Stromal cell-derived factor 1α ...... d therapy in pancreatic cancer
@en
P2093
Belen Rubio-Viqueira
Colin D Weekes
Dongweon Song
Elizabeth Garrett-Mayer
George Cusatis
John Arcaroli
Lora A Wilson
Manuel Hidalgo
Robert A Winn
Wells A Messersmith
P2860
P304
P356
10.1593/NEO.111810
P577
2012-08-01T00:00:00Z